单核/巨噬细胞在非霍奇金淋巴瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2020.04.011

Abstract

Abstract: Non-Hodgkin's lymphoma(NHL)is a general term for a group of independent diseases with strong heterogeneity.In recent years,it's been found that in the tumor microenvironment,monocytes/macrophages have a certain effects on tumor growth,proliferation,immune escape and prognosis.At the same time,tumors also stimulate monocytes/macrophages.This article summarizes the current research status of monocytes/macrophages in several common NHL,summarizes the correlation between monocytes/macrophages and the prognosis of NHL patients,the interaction and mechanism of monocytes/macrophages and NHL tumor cells,and describes the possible role of monocytes/macrophages in immunotherapy of NHL.

Key words: Non-Hodgkin's lymphoma, Monocyte, Macrophage, Tumor-associated macrophages, Immuno-therapy

CLC Number:

R733.4

LIN Yingxi, LONG Yayi, FU Junhong, LIU Fang, CHEN Minmin. Research progress of monocytes/macrophages in non-hodgkin's lymphomas[J]. Journal of Practical Oncology, 2020, 34(4): 352-356.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.04.011

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I4/352

References

1 Zhou X,Pan H,Yang P,et al.Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma[J].BMC Cancer,2019,19(1):477.
2 Ansell SM.Non-hodgkin lymphoma:diagnosis and treatment[J].Mayo Clin Proc,2015,90(8):1152-1163.
3 Miranda-Filho A,Piñeros M,Znaor A,et al.Global patterns and trends in the incidence of non-hodgkin lymphoma[J].Cancer Causes Control,2019,30(5):489-499.
4 Yamaguchi M,Suzuki R,Oguchi M.Advances in the treatment of extranodal NK/T-cell lymphoma,nasal type[J].Blood,2018,131(23):2528-2540.
5 Brown JM,Recht L,Strober S.The promise of targeting macrophages in cancer therapy[J].Clin Cancer Res,2017,23(13):3241-3250.
6 Mantovani A,Marchesi F,Malesci A,et al.Tumour-associated macrophages as treatment targets in oncology[J].Nat Rev Clin Oncol,2017,14(7):399-416.
7 欧阳明祈.PD-1表达水平对非霍金淋巴瘤中肿瘤相关巨噬细胞功能影响的研究[D].北京:北京协和医学院,2018.
8 Wu C,Wu X,Liu X,et al.Prognostic significance of monocytes and monocytic myeloid-derived suppressor cells in diffuse large B-cell lymphoma treated with r-chop[J].Cell Physiol Biochem,2016,39(2):521-530.
9 George A,Prince HM,Szer J,et al.Prognostic impact of monocyte count at presentation in mantle cell lymphoma[J].Br J Haematol,2014,164(6):890-893.
10 Wang H,Li P,Wang L,et al.High numbers of CD68⁺ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma,nasal type[J].Ann Hematol,2015,94(9):1535-1544.
11 Kato A,Imai Y,Aoki K,et al.Serum IgA level,monocyte count,and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma[J].Ann Hematol,2014,93(7):1185-1191.
12 Yang YQ,Liang JH,Wu JZ,et al.Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma[J].Leuk Res,2016,42:88-92.
13 Lee SF,Luque-Fernandez MA.Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma:a retrospective cohort study[J].BMJ Open,2017,7(11):e017904.
14 Li N,Zhang L,Song HL,et al.Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type,extranodal natural killer/T-cell lymphoma[J].Tumour Biol,2017,(39)5:1-11.
15 Li Q,Gao S,Ma J,et al.A lower ALC/AMC ratio is associated with poor prognosis of peripheral T cell lymphoma-not otherwise specified[J].Leuk Res,2018,73:5-11.
16 Jia T,Zhang R,Zhu HY,et al.Prognostic significance of peripheral blood absolute monocyte count and lymphocyte to monocyte ratio in anaplastic large cell lymphoma[J].Cancer Biomark,2018,22(4):807-813.
17 Matsuki E,Bohn OL,EI Jamal S,et al.Lymphocyte-to-monocyte ratio may serve as a better prognostic indicator than tumor-associated macrophages in DLBCL treated with rituximab[J].Appl Immunohistochem Mol Morphol,2019,27(8):572-580.
18 Sugimoto T,Watanabe T.Follicular lymphoma:the role of the tumor microenvironment in prognosis[J].J Clin Exp Hematop,2016,56(1):1-19.
19 Lin ZX,Bai B,Cai QC,et al.High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T-and natural killer cell lymphomas[J].Med Oncol,2012,29(5):3522-3528.
20 Liu Y,Fan L,Wang Y,et al.Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma[J].Int J Clin Exp Pathol,2014,7(9):5429-5435.
21 Ham JS,Park HY,Ryu KJ,et al.Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma[J].Oncotarget,2017,8(44):76231-76240.
22 Niino D,Komohara Y,Murayama T,et al.Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma(AITL)[J].PatholInt,2010,60(4):278-283.
23 Pedersen MB,Danielsen AV,Hamilton-Dutoit SJ,et al.High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma[J].Histopathology,2014,65(4):490-500.
24 Komohara Y,Niino D,Saito Y,et al.Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma[J].Cancer Sci,2013,104(7):945-951.
25 Sugaya M,Miyagaki T,Ohmatsu H,et al.Association of the numbers of CD163⁺ cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma[J].J Dermatol Sci,2012,68(1):45-51.
26 Zhang W,Wang L,Zhou D,et al.Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma,not otherwise specified[J].Leuk Lymphoma,2011,52(1):46-52.
27 Noyori O,Komohara Y,Nasser H,et al.Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphoma[J].Clin Transl Immunology,2019,8(8):e1074.
28 Ishii H,Takahara M,Nagato T,et al.Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact dependent interaction through membrane-bound IL-15[J].Int J Cancer,2012,130(1):48-58.
29 Xiu B,Lin Y,Grote DM,et al.IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-)monocytes in B-cell non-Hodgkin lymphoma[J].Blood Cancer J,2015,31:e328.
30 Voss JJLP,Ford CA,Petrova S,et al.Modulation of macrophage antitumor potential by apoptotic lymphoma cells[J].Cell Death Differ,2017,24(6):971-983.
31 Mendoza-Coronel E,Ortega E.Macrophage polarization modulates FcgR-and CD13-mediated phagocytosis and reactive oxygen species production,independently of receptor membrane expression[J].Front Immunol,2017,8:303.
32 Chaudhari P,Ye Z,Jang YY.Roles of reactive oxygen species in the fate of stem cells[J].Antioxid Redox Signal,2014,20(12):1881-1890.
33 Lin YM,Huang YL,Fong YC,et al.Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-met receptor pathway[J].PLoS One,2012,7(11):e50924.
34 Huang W,Wei X,Wei Y,et al.Biology of tumor associated macrophages in diffuse large B cell lymphoma[J].DNA Cell Biol,2018[Online ahead of print].
35 Vari F,Arpon D,Keane C,et al.Immune evasion via PD-1/PD-L1 on NK-Cells and monocyte/macrophages is more prominent in hodgkin lymphoma than DLBCL[J].Blood,2018,131(16):1809-1819.
36 McKee SJ,Tuong ZK,Kobayashi T,et al.B cell lymphoma progression promotes the accumulation of circulating Ly6C^lo monocytes with immunosuppressive activity[J].Oncoimmunology,2017,7(2):e1393599.
37 Church AK,VanDerMeid KR,Baig NA,et al.Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages[J].Clin Exp Immunol,2016,183(1):90-101.
38 Sawas A,Farber CM,Schreeder MT,et al.A phase 1/2 trial of ublituximab,a novel anti-CD20 monoclonal antibody,in patients with B-cell non-hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab[J].Br J Haematol,2017,177(2):243-253.
39 Chao MP,Alizadeh AA,Tang C,et al.Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-hodgkin lymphoma[J].Cell,2010,142(5):699-713.
40 Advani R,Flinn I,Popplewell L,et al.CD47 blockade by Hu5F9-G4 and rituximab in non-hodgkin's lymphoma[J].N Engl J Med,2018,379(18):1711-1721.
41 He J,Hu Y,Hu M,et al.Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer[J].Sci Rep,2015,5:13110.
42 Kwong YL,Chan TSY,Tan D,et al.PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase[J].Blood,2017,129(17):2437-2442.
43 Lesokhin AM,Ansell SM,Armand P,et al.Nivolumab in patients with relapsed or refractory hematologic malignancy:preliminary results of a phase ib study[J].J Clin Oncol,2016,34(23):2698-2704.
44 Priceman SJ,Sung JL,Shaposhnik Z,et al.Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1receptor:combating tumor evasion of antiangiogenic therapy[J].Blood,2010,115(7):1461-1471.

[1]	FAN Xiaona,WANG Dan,LI Qingwei,LI Zhiwei. Advances in research on adjuvant drug threapy for postoperative pancreatic cancer [J]. Journal of Practical Oncology, 2020, 34(3): 249-253.
[2]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[3]	ZHANG Pei, CAO Shoubo, YU Yan. Research progress of autophagy-mediated regulation of tumor associated macrophages [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 130-134.
[4]	TANG Mengmeng, LIU Tianbo, WANG Jing. Recent advances in prognosis of LMR associated with gynecological malignancies [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 569-572.
[5]	ZHANG Aiqi,JIN Shi,CAO Shoubo,YU Yan. Prognostic value of lymphocyte-to-monocyte ratio in the patients with malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 188-192.
[6]	YU Changyan, ZHEN Lina, LI Hongbing, ZHANG Yue, ZHANG Qingyuan. The correlations between expression of tumor associated macrophages and the prognostic significances in triple negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 1-6.
[7]	ZHEN Lina,YU Changyan,LI Hongbin,ZHANG Yue,ZHANG Qingyuan. Research progress on recurrence and metastasis factors for node negative breast cancer and its impact on treatment decisions [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(2): 183-187.
[8]	ZHANG Yue, ZHANG Qingyuan, MA Wenjie, ZHEN Lina. High-infiltration of tumor-associated macrophages predicted unfavorable clinical outcome for node-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2013, 27(4): 289-294.

Research progress of monocytes/macrophages in non-hodgkin's lymphomas

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 8

Recommended Articles

Metrics

Comments